Tonix Pharmaceuticals
TNXP
#8315
Rank
ยฃ0.17 B
Marketcap
ยฃ14.73
Share price
0.56%
Change (1 day)
4.34%
Change (1 year)

Revenue for Tonix Pharmaceuticals (TNXP)

Revenue in 2025 (TTM): ยฃ7.83 Million

According to Tonix Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ7.72 Million. In 2024 the company made a revenue of ยฃ8.04 Million an increase over the revenue in the year 2023 that were of ยฃ6.09 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Tonix Pharmaceuticals from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ7.83 M-2.53%
2024 ยฃ8.04 M31.92%
2023 ยฃ6.09 M
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Aerie Pharmaceuticals
AERI
ยฃ0.16 B 1,977.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
ยฃ0.19 B 2,400.74%๐Ÿ‡บ๐Ÿ‡ธ USA